Quality of life in people living with HIV in Romania and Spain
Open Access
- 13 September 2021
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 21 (S2) , 1-20
Abstract
Background: Health-related quality of life (HRQoL) is a crucial component in assessing and addressing the unmet needs of people, especially those with chronic illnesses such as HIV. The aim of the study was to examine and compare the health-related quality of life of people living with HIV in Romania and Spain, compared to the general populations of each country. Methods: A cross-sectional survey was conducted among adults (≥ 18 years) attending for HIV care in Romania and Spain from October 2019 to March 2020. The survey included two validated HRQoL instruments: a generic instrument, EQ-5D-5L, and an HIV-specific instrument, PozQoL, and questions on socio-demographics, HIV-related characteristics, physical and mental health conditions, and substance use. Multivariable linear regression was used to determine factors associated with HRQoL. Results: 570 people living with HIV responded (170 in Romania and 400 in Spain). The median age was 31 (18–67) in Romania and 52 (19–83) in Spain. Anxiety/depression symptoms were frequently reported by people with HIV (Romania: 50% vs 30% in the Romanian population; Spain: 38% vs 15% in Spanish population). Spain reported higher mean EQ-5Dutility scores than Romania (0.88 and 0.85, respectively) but identical PozQoL scores (3.5, on a scale of 0–5). In both countries, health concerns were highlighted as a key issue for people with HIV. In multivariable analysis, two factors were consistently associated with worse HRQoL in people with HIV: bad or very bad self-rated health status and presence of a mental health condition. In Romania, being gay/bisexual and being disabled/unemployed were associated with worse HRQoL. Whereas in Spain, older age and financial insecurity were significant predictors. Conclusions: Our results indicated a good HRQoL for people living with HIV in Romania and Spain; however, worse HRQoL profiles were characterized by health concerns, poor self-rated health status, and the presence of mental health conditions. This study highlights the importance of monitoring HRQoL in people living with HIV due to the chronic nature of the disease. In this highly-treatment experienced group, disparities were found, particularly highlighting mental health as an area which needs more attention to improve the well-being of people living with HIV.Keywords
Funding Information
- Executive Agency for Health and Consumers (761319)
This publication has 27 references indexed in Scilit:
- Beyond viral suppression of HIV – the new quality of life frontierBMC Medicine, 2016
- Validity and reliability of the HeartQoL questionnaire in a large sample of stable coronary patients: The EUROASPIRE IV Study of the European Society of CardiologyEuropean Journal of Preventive Cardiology, 2015
- Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general populationThe Lancet HIV, 2014
- Experience of persistent psychological symptoms and perceived stigma among people with HIV on antiretroviral therapy (ART): A systematic reviewInternational Journal of Nursing Studies, 2014
- Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologicsThe European Journal of Health Economics, 2014
- Health technology assessment in Poland, the Czech Republic, Hungary, Romania and BulgariaThe European Journal of Health Economics, 2014
- Responsiveness of the MOS-HIV and EQ-5D in HIV-infected adults receiving antiretroviral therapiesHealth and Quality of Life Outcomes, 2013
- The Development of PROQOL-HIVJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- An International Quality of Life Instrument to Assess Wellbeing in Adults Who are HIV-Positive: A Short Form of the WHOQOL-HIV (31 items)AIDS and Behavior, 2010
- Substance Abuse and Psychiatric Disorders in HIV-Positive PatientsDrugs, 2006